N/A
Completed N=996
Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®
Glaucoma,Open-Angle · Hypertension
Source: ClinicalTrials.gov NCT00486252 ↗
Enrolled (actual)
996
Serious AEs
0.0%
Results posted
Jul 2009
Primary outcomePrimary: Change in Intraocular Pressure (IOP): Baseline to Month 3 — -5.3; -6.8; -4.1 mmHg
Summary
The primary objective is to evaluate the Intraocular pressure reducing effect of Xalatan over 3 months. The secondary objective is to study the other efficacy parameters during treatment for 3 months
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Intraocular Pressure (IOP): Baseline to Month 3 |
-5.3; -6.8; -4.1 | — |
| SECONDARY Percentage Change in Intraocular Pressure (IOP) |
-19.2; -22.6; -16.5; -21.5; -26.1; -18.1 | — |
| SECONDARY Categorized Percentage Change in Intraocular Pressure (IOP) |
69; 10; 58; 422; 145; 274 | — |
Eligibility Criteria
Inclusion Criteria
- Unilateral or bilateral open angle glaucoma or ocular hypertension (IOP (Intraocular Pressure) ≥ 21 mmHg at diagnosis).
- Naive patients (no prior anti-glaucoma pharmacological or surgical treatment) and patients with beta-blockers therapy failure
- Visual acuity (best corrected) equal to or better than 6/6
Exclusion Criteria
- closed/barely open anterior chamber angle or history of acute angle closure glaucoma.
- history of any antiglaucoma surgical treatment (Argon Laser Trabeculoplasty and/or any ocular filtering surgical intervention).
- ocular surgery (on the globe of the eye only), or inflammation/infection within 3 months prior to baseline visit. (Applies to both fellow and study eyes.)
- other abnormal ocular conditions or symptoms preventing the patient from entering the study, in the investigator's clinical judgement.
Data sourced from ClinicalTrials.gov (NCT00486252). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.